Sep 22, 2023 09:04AM
Sep 22, 2023 08:30AM
Sep 11, 2023 11:53AM
Sep 11, 2023 11:51AM
Sep 8, 2023 02:30PM
Aug 9, 2023 08:47AM
Jul 20, 2023 08:00AM Hillstream Advances Next-Gen Multispecific Antibodies for Solid Tumors with Lead HER2/HER3 Program, HSB-3215
Jul 10, 2023 08:47AM
Jul 10, 2023 08:47AM
Jul 6, 2023 08:30AM
May 15, 2023 08:49AM
May 15, 2023 08:47AM
May 2, 2023 08:47AM
Apr 28, 2023 04:16AM Hillstream BioPharma (HILS) Prices 5.3M Share Offering at $0.50/sh
Apr 27, 2023 09:50PM
Apr 27, 2023 04:01PM
Apr 27, 2023 04:00PM
Apr 13, 2023 08:48AM
Apr 13, 2023 08:47AM
Apr 10, 2023 08:47AM
Apr 10, 2023 08:47AM Hillstream BioPharma Announces Pharmacokinetic Data of HSB-1216 Supportive of its Development Strategy and Pre-clinical Data
Feb 28, 2023 09:45AM
Feb 15, 2023 07:12AM
Feb 15, 2023 07:11AM
Feb 13, 2023 04:15PM
Feb 13, 2023 07:13AM
Feb 13, 2023 07:11AM
Feb 10, 2023 07:18AM Hillstream BioPharma (HILS) Reports HSB-1216 and Pembrolizumab Demonstrated Significantly Greater Tumor Inhibition in Calu-1
Feb 10, 2023 07:17AM
Feb 8, 2023 07:11AM
Feb 6, 2023 07:00AM
Jan 31, 2023 07:12AM
Jan 31, 2023 07:11AM
Jan 17, 2023 11:29AM
Dec 1, 2022 08:47AM Hillstream BioPharma (HILS) Announces Development of Proprietary Targeted Biologics, Knob Quatrabodies (HSB-1940) against PD-1
Dec 1, 2022 08:47AM
Nov 22, 2022 06:30AM
Oct 18, 2022 08:47AM
Oct 6, 2022 08:47AM
Sep 14, 2022 08:47AM
Jul 8, 2022 08:17AM
Jun 27, 2022 08:28AM Hillstream BioPharma (HILS) Collaborates with Sapien Biosciences in Cancer Treatments
Jun 27, 2022 08:27AM
Jun 13, 2022 08:03AM
Jun 13, 2022 08:00AM
Jun 2, 2022 08:47AM
Jun 2, 2022 08:47AM
May 5, 2022 08:47AM
Mar 2, 2022 08:37AM Hillstream BioPharma (HILS) Highlights Ferroptosis, the Non-Genetic Novel, Emerging Mechanism of Action, Targeting Drug Resistant and Devastating Cancers
Mar 2, 2022 08:37AM

312,667 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All